Who’s Hired? Alvotech Names New COO After Refiling Adalimumab

As Strides’ Strategy Head Departs And Haggar Becomes Biocon Director

 
• By David Wallace
  
Revolving Doors Executives Blurred
The latest executive changes across the off-patent industry • Source: Shutterstock

More from Leadership

More from Generics Bulletin